Your browser doesn't support javascript.
loading
Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives.
Kaló, Zoltán; Petykó, Zsuzsanna Ida; Fricke, Frank-Ulrich; Maniadakis, Nikos; Tesar, Tomás; Podrazilová, Katerina; Espin, Jaime; Inotai, András.
Afiliação
  • Kaló Z; Center for Health Technology Assessment, Semmelweis University, Ülloi rd. 25, 1085, Budapest, Hungary.
  • Petykó ZI; Pharmaceutical Policy Research, Syreon Research Institute, Mexikói str. 65/A, 1142, Budapest, Hungary.
  • Fricke FU; Center for Health Technology Assessment, Semmelweis University, Ülloi rd. 25, 1085, Budapest, Hungary.
  • Maniadakis N; Pharmaceutical Policy Research, Syreon Research Institute, Mexikói str. 65/A, 1142, Budapest, Hungary.
  • Tesar T; Technische Hochschule Nürnberg, Nürnberg, Germany.
  • Podrazilová K; Department of Public Health Policies, Sector of Health Systems and Policy, School of Public Health, University of West Attica, Athens, Greece.
  • Espin J; Department of Organisation and Management of Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia.
  • Inotai A; Association of Health Insurance Companies, Prague, Czech Republic.
Cost Eff Resour Alloc ; 19(1): 42, 2021 Jul 15.
Article em En | MEDLINE | ID: mdl-34266465
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Evaluation_studies / Prognostic_studies Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Evaluation_studies / Prognostic_studies Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2021 Tipo de documento: Article